Astera Labs, Inc. $ALAB Shares Sold by Barclays PLC

Barclays PLC lessened its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 40.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,150,080 shares of the company’s stock after selling 779,776 shares during the quarter. Barclays PLC’s holdings in Astera Labs were worth $191,327,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Analog Century Management LP purchased a new position in Astera Labs in the fourth quarter worth approximately $51,407,000. CreativeOne Wealth LLC grew its position in Astera Labs by 24.6% in the fourth quarter. CreativeOne Wealth LLC now owns 2,313 shares of the company’s stock worth $385,000 after acquiring an additional 456 shares during the period. Kestra Advisory Services LLC grew its position in Astera Labs by 159.0% in the fourth quarter. Kestra Advisory Services LLC now owns 29,753 shares of the company’s stock worth $4,950,000 after acquiring an additional 18,267 shares during the period. Marshall Wace LLP grew its position in Astera Labs by 16.7% in the fourth quarter. Marshall Wace LLP now owns 348,296 shares of the company’s stock worth $57,943,000 after acquiring an additional 49,882 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in Astera Labs by 4,254.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 299,294 shares of the company’s stock worth $49,829,000 after acquiring an additional 292,420 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on ALAB shares. Stifel Nicolaus increased their price objective on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Susquehanna increased their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

ALAB opened at $367.15 on Monday. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $390.99. The business has a fifty day simple moving average of $237.17 and a 200-day simple moving average of $179.16. The firm has a market cap of $62.93 billion, a P/E ratio of 248.07, a P/E/G ratio of 4.86 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the business posted $0.33 earnings per share. The company’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 2,318,756 shares of company stock valued at $480,568,146. 10.40% of the stock is owned by company insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.